APVO
Aptevo Therapeutics·NASDAQ
--
--(--)
--
--(--)
APVO Filings
Filing Date
Form Description
Form Type
2026-03-26
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-26 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-26
Form 8-K - Current report
Key Events
2026-03-26 · Key Events
Form 8-K - Current report
2026-03-11
Form 8-K - Current report
Key Events
2026-03-11 · Key Events
Form 8-K - Current report
2026-02-19
Form 8-K - Current report
Key Events
2026-02-19 · Key Events
Form 8-K - Current report
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-03
Form 8-K - Current report
Key Events
2026-02-03 · Key Events
Form 8-K - Current report
2026-02-02
Form EFFECT - Notice of Effectiveness
2026-02-02 ·
Form EFFECT - Notice of Effectiveness
2026-01-30
Form 424B4 - Prospectus [Rule 424(b)(4)]
2026-01-30 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2026-01-28
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-28 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
